Susan Mahony, Ph.D.
Senior Vice President and President, Lilly Oncology
Eli Lilly and Company
Sue Mahony is a senior vice president of Eli Lilly and Company and president of Lilly Oncology.
Sue joined Lilly in 2000 after more than 10 years in sales and marketing roles in the United Kingdom and Europe in oncology, hematology and cardiovascular medicine for Schering-Plough, Amgen, and Bristol-Myers Squibb. At Lilly, Sue has worked in product development, Six Sigma, marketing and general management roles. After leading Lilly’s operations in Canada, Sue was appointed senior vice president of human resources and diversity, before assuming her current role in 2011.
Sue earned a bachelor’s degree in pharmacy from Aston University in the U.K., and a Ph.D. in pharmacy in Aston’s Cancer Research Campaign’s experimental chemotherapy group. She also earned a master’s degree in business administration from the London Business School. In 2012, Sue received an honorary doctorate from Aston University.
In 2010, Mahony was recognized as one of the Indianapolis Business Journal’s “Women of Influence.” Mahony served on the board of the United Way of Central Indiana from 2010 to 2012 and has served on the Board of Directors of Park Tudor School since 2015. In December 2017, Mahony joined the Board of Directors of Assembly Biosciences, Inc.